Submissions from 2017
Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature., Daniel E Ezekwudo and Ishmael Jaiyesimi
Primary Extranodal Diffuse Large B-Cell Lymphoma of the Prostate: A Case Report., Daniel E Ezekwudo, Foluso Ogunleye, Bolanle Gbadamosi, LeAnn M Blankenship, and Ishmael Jaiyesimi
The Clinical Characteristics, Genetic Alterations and Prognostic Significance of Acute Myeloid Leukemia (AML) with Trisomy 8, Bolanle Gbadamosi, Daniel E. Ezekwudo, Foluso Ogunleye, Zhou Yu, Michael Stender, Dana Zakalik, Ishmael Jaiyesimi, and Mark Micale
Case for Stopping Targeted Therapy When Lung Cancer Progresses on Treatment in Hospice-Eligible Patients., Ishmael Jaiyesimi
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update., Ishmael Jaiyesimi
Representation of minorities and elderly in cancer clinical trials at a single institution-The William Beaumont Hospital experience, Foluso Ogunleye
Crizanlizumab in Sickle Cell Disease., Zhou Yu, LeAnn Blankenship, and Ishmael Jaiyesimi
Excellent Response with Ado-Trastuzumab Emtansine in a Patient with Relapsed Metastatic Breast Cancer Presenting with Pulmonary Lymphangitic Carcinomatosis., Zhou Yu and Marianne Huben
Unusual Presentation of a Small-Cell Variant of Anaplastic Large-Cell Lymphoma Case: When a Septic Picture Is Not Sepsis, Zhou Yu, Yifan Pang, Linda Wang, Daniel E. Ezekwudo, Foluso Ogunleye, Susanna S. Gaikazian, Mark Micale, James Huang, Ann Marie Blenc, and Ishmael Jaiyesimi